Compare KALA & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALA | YCBD |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 4.5M |
| IPO Year | 2017 | N/A |
| Metric | KALA | YCBD |
|---|---|---|
| Price | $0.68 | $1.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $31.50 | $2.00 |
| AVG Volume (30 Days) | ★ 21.5M | 1.0M |
| Earning Date | 11-19-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $19,026,064.00 |
| Revenue This Year | N/A | $0.37 |
| Revenue Next Year | N/A | $4.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.61 | $0.47 |
| 52 Week High | $20.60 | $6.54 |
| Indicator | KALA | YCBD |
|---|---|---|
| Relative Strength Index (RSI) | 36.22 | 76.93 |
| Support Level | $0.67 | $0.60 |
| Resistance Level | $0.86 | $0.67 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | 0.09 | 0.06 |
| Stochastic Oscillator | 5.09 | 71.23 |
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.